Clinical Operations Consultant (Oncology)
This job is no longer available
There are still lots of open positions. Let's find the one that's right for you.
About The Position
MOMA Therapeutics is a clinical-stage, next-generation precision medicine company dedicated to targeting highly dynamic proteins that underlie human disease via a small molecule approach, utilizing its proprietary KNOMATICTM platform. The platform was designed to exploit key vulnerabilities inherent to all dynamic proteins, namely their dependence on well-coordinated, stepwise changes in protein conformation. By focusing on genetically validated targets with high translation potential, MOMA is rapidly advancing its pipeline toward responses in the clinic. MOMA's lead assets include: MOMA-313 - A selective polymerase helicase theta inhibitor in Phase 1, MOMA-989 - A next generation selective PARP1 inhibitor currently in IND enabling studies, MOMA-341 - A selective Werner helicase inhibitor in Phase 1. MOMA's pre-clinical pipeline consists of wholly-owned assets and discovery partnerships with Roche and Bayer.
